Butterfly Network Shares Rise 22% After FDA Clearance of Ultrasound System
By Chris Wack
Butterfly Network shares were up 22% to $1.23 after the company received Food and Drug Administration clearance of its next-generation handheld point-of-care ultrasound system, Butterfly iQ3.
The stock has risen 36% in the last month, but is down 45% in the past year.
The digital health company said the new device is its third iteration of the world's first semiconductor-based single-probe, whole-body ultrasound system.
Butterfly iQ3 features include a new ergonomic design and it will deliver double the data processing speed for optimized image resolution, sensitivity and penetration.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
January 08, 2024 12:38 ET (17:38 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks